Key Insights The projected fair value for Rambus is US$88.50 based on 2 Stage Free Cash Flow to Equity Rambus' ...
Investing.com -- Dogwood Therapeutics Inc (NASDAQ:DWTX) stock plunged 24.7% on Monday after the company released interim analysis results from its ongoing Phase 2b trial for Halneuron®, its treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback